Cargando…
The Influence of the CES1 Genotype on the Pharmacokinetics of Enalapril in Patients with Arterial Hypertension
The angiotensin-converting enzyme inhibitor enalapril is hydrolysed to an active metabolite, enalaprilat, in the liver via carboxylesterase 1 (CES1). Previous studies show that variant rs71647871 in the CES1 gene affects the pharmacokinetics of enalapril on liver samples as well as healthy volunteer...
Autores principales: | Ikonnikova, Anna, Rodina, Tatiana, Dmitriev, Artem, Melnikov, Evgeniy, Kazakov, Ruslan, Nasedkina, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028383/ https://www.ncbi.nlm.nih.gov/pubmed/35455696 http://dx.doi.org/10.3390/jpm12040580 |
Ejemplares similares
-
The Influence of Structural Variants of the CES1 Gene on the Pharmacokinetics of Enalapril, Presumably Due to Linkage Disequilibrium with the Intronic rs2244613
por: Ikonnikova, Anna, et al.
Publicado: (2022) -
Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008) -
Lercanidipine/enalapril combination in the management of obesity-related hypertension
por: Grassi, Guido
Publicado: (2016) -
Clinical Pharmacokinetics of Enalapril and Enalaprilat in Pediatric Patients—A Systematic Review
por: Faisal, Muhammad, et al.
Publicado: (2021) -
Enalapril Influence on Arterial Stiffness in Rheumatoid Arthritis Women: A Randomized Clinical Trial
por: Perez-Vazquez, Felipe, et al.
Publicado: (2020)